Class information for:
Level 1: CANDESARTAN CILEXETIL//ANGIOTENSIN II RECEPTOR ANTAGONIST//LOSARTAN

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
3886 1815 32.1 72%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
132 22818 ANGIOTENSIN II//ANGIOTENSIN 1 7//RENIN ANGIOTENSIN SYSTEM

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CANDESARTAN CILEXETIL Author keyword 60 50% 5% 87
2 ANGIOTENSIN II RECEPTOR ANTAGONIST Author keyword 34 33% 5% 84
3 LOSARTAN Author keyword 26 11% 12% 217
4 AZILSARTAN MEDOXOMIL Author keyword 21 78% 1% 14
5 IRBESARTAN Author keyword 21 22% 5% 86
6 FIMASARTAN Author keyword 21 75% 1% 15
7 EPROSARTAN Author keyword 18 38% 2% 38
8 ANGIOTENSIN II ANTAGONIST Author keyword 15 37% 2% 33
9 INSURMOUNTABLE Author keyword 15 73% 1% 11
10 VALSARTAN Author keyword 14 13% 5% 96

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 CANDESARTAN CILEXETIL 60 50% 5% 87 Search CANDESARTAN+CILEXETIL Search CANDESARTAN+CILEXETIL
2 ANGIOTENSIN II RECEPTOR ANTAGONIST 34 33% 5% 84 Search ANGIOTENSIN+II+RECEPTOR+ANTAGONIST Search ANGIOTENSIN+II+RECEPTOR+ANTAGONIST
3 LOSARTAN 26 11% 12% 217 Search LOSARTAN Search LOSARTAN
4 AZILSARTAN MEDOXOMIL 21 78% 1% 14 Search AZILSARTAN+MEDOXOMIL Search AZILSARTAN+MEDOXOMIL
5 IRBESARTAN 21 22% 5% 86 Search IRBESARTAN Search IRBESARTAN
6 FIMASARTAN 21 75% 1% 15 Search FIMASARTAN Search FIMASARTAN
7 EPROSARTAN 18 38% 2% 38 Search EPROSARTAN Search EPROSARTAN
8 ANGIOTENSIN II ANTAGONIST 15 37% 2% 33 Search ANGIOTENSIN+II+ANTAGONIST Search ANGIOTENSIN+II+ANTAGONIST
9 INSURMOUNTABLE 15 73% 1% 11 Search INSURMOUNTABLE Search INSURMOUNTABLE
10 VALSARTAN 14 13% 5% 96 Search VALSARTAN Search VALSARTAN

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DUP 753 196 55% 14% 247
2 ACTIVE ANTIHYPERTENSIVE AGENT 94 53% 7% 126
3 CV 11974 67 76% 3% 47
4 POTENT ANTIHYPERTENSIVES 62 80% 2% 39
5 DUP753 57 95% 1% 19
6 LOSARTAN 42 15% 14% 257
7 II RECEPTOR ANTAGONIST 42 27% 7% 131
8 TO MODERATE HYPERTENSION 34 28% 6% 104
9 CANDESARTAN CILEXETIL 30 41% 3% 57
10 EXP3174 30 62% 2% 31

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists 2013 31 456 43%
Angiotensin II receptor antagonists 2000 315 81 49%
Angiotensin II type 1 receptor blockers 2001 255 100 50%
Angiotensin II receptor type 1 (AT(1)) selective nonpeptidic antagonists-A perspective 2010 28 257 76%
Valsartan - A review of its pharmacology and therapeutic use in essential hypertension 1997 209 22 77%
Systematic review: Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension 2008 139 78 28%
Nonpeptide angiotensin II receptor antagonists: The next generation in antihypertensive therapy 1996 228 200 70%
Telmisartan - A review of its use in hypertension 2001 106 47 60%
Antihypertensive activity of angiotensin II AT(1) receptor antagonists: a systematic review of studies with 24h ambulatory blood pressure monitoring 2007 40 60 58%
Clinical pharmacokinetics of Losartan 2005 42 100 58%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SMITHKLINE BEECHAM CLIN PHARMACOL UNIT 6 50% 0.4% 8
2 HYPERTENS VASC MED 4 16% 1.4% 25
3 KOTOBUKI S 4 75% 0.2% 3
4 MOL BIOCHEM PHARMACOL 2 12% 1.1% 20
5 CARDIOL HYPERTENS UNIT 2 67% 0.1% 2
6 TRINITY HYPERTENS 2 67% 0.1% 2
7 MOL CARDIOVASC THER EUT 2 28% 0.3% 5
8 STARNBERG HOSP 1 25% 0.3% 5
9 BIOORGAN SCI 5 1 100% 0.1% 2
10 COMMUNITY EMERGENCY 1 50% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000185466 SMALL ANGLE AND WIDE ANGLE X RAY SCATTERING//ARETAIEO UNIV HOSP//MMK3
2 0.0000184185 UNITE PHYSIOL INTEGREE//ANGIOTENSIN II AT1 RECEPTOR ANTAGONIST//PATHOL VASC
3 0.0000180437 ADR MONITORING//BOVINE BRONCHI//ACE I INHIBITOR
4 0.0000149084 AT2 RECEPTOR//COMPOUND 21//ANGIOTENSIN RECEPTORS
5 0.0000121730 HYDROCHLOROTHIAZIDE//AMLODIPINE BESYLATE//LOSARTAN POTASSIUM
6 0.0000096673 AMLODIPINE//BLOOD PRESSURE CONTROL//ANTIHYPERTENSIVE THERAPY
7 0.0000088671 TELMISARTAN//ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER//CLIN TRIAL MANAGEMENTITABASHI KU
8 0.0000075811 ZOFENOPRIL//INFARCT EXPANSION//ANGIOTENSIN II AT1 RECEPTOR BLOCKADE
9 0.0000064878 DUAL BLOCKADE//RENOPROTECTION//NONDIABETIC RENAL DISEASE
10 0.0000060842 ALISKIREN//PRORENIN RECEPTOR//DIRECT RENIN INHIBITOR